By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
When people are impacted by diseases, they deserve the best possible treatment. Unfortunately, for many people there are still no effective treatments. With new discoveries in biology and technology, we are learning more every day about how to successfully develop revolutionary medicines and make them available to patients worldwide.
It is crucially important for Amgen to continue to invest in the discovery, development, improvement and availability of our innovative therapies that serve patients. Together with the government, healthcare providers and health insurers, Amgen is constantly looking for ways to give patients faster and sustainable access to our medicines. We want to be as open and transparent as possible about all our efforts. Click on the icons below for more information.
